Further use of antitumor therapies based on DDR1 inhibition requires a more in-depth knowledge of cell-specific DDR1 expression and signaling, the mechanisms that activate its signaling, and its functional implication in tumor growth and dissemination. Here, DDR1 is linked to neoplasm.